Drugs / Personalized multi-peptide vaccine
re-read 2 minutes ago

Personalized multi-peptide vaccine

Vaccine

Developed for
cancer
Investigated by
University Hospital Tuebingen

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT05014607 cancer University Hospital Tuebingen Available No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Personalized multi-peptide vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT05014607
Modality Vaccine “Personalized multi-peptide vaccine cocktails” NCT05014607
Route Subcutaneous “Peptides will be administered subcutaneously (s.c.)” NCT05014607